Cart
sales@molnova.com
p38-α MAPK-IN-1
CAS No. 443913-15-3
p38-α MAPK-IN-1( —— )
Catalog No. M26355 CAS No. 443913-15-3
p38-α MAPK-IN-1 is a MAPK14 (p38-α) inhibitor with IC50 of 2300 nM and 5500 nM in EFC displacement assay and HTRF assay,respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 230 | Get Quote |
|
| 10MG | 372 | Get Quote |
|
| 25MG | 623 | Get Quote |
|
| 50MG | 887 | Get Quote |
|
| 100MG | 1197 | Get Quote |
|
| 500MG | 2394 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Namep38-α MAPK-IN-1
-
NoteResearch use only, not for human use.
-
Brief Descriptionp38-α MAPK-IN-1 is a MAPK14 (p38-α) inhibitor with IC50 of 2300 nM and 5500 nM in EFC displacement assay and HTRF assay,respectively.
-
Descriptionp38-α MAPK-IN-1 is a MAPK14 (p38-α) inhibitor with IC50 of 2300 nM and 5500 nM in EFC displacement assay and HTRF assay,respectively.(In Vitro):p38-α MAPK-IN-1 is a MAPK14 (p38-α) inhibitor(IC50 of 2300 nM, in EFC displacement assay, and 5500 nM in HTRF assay).
-
In Vitrop38-α MAPK-IN-1 (Compound 12) is an inhibitor of MAPK14 (p38-α)>, with IC50 of 2300 nM in EFC displacement assay, and 5500 nM in HTRF assay.
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
Targetp38 MAPK
-
RecptorAntibacterial| Antiviral| Bacterial| HSV-1| Human Endogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number443913-15-3
-
Formula Weight477.609
-
Molecular FormulaC27H35N5O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (209.38 mM)
-
SMILESCc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(OCCN2CCOCC2)cc1)C(C)(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Morales-Nin B, Grau A, Pérez-Mayol S, Pastor E, Palmer M. Oxytetracycline hydrochloride vital labelling revisited: the case of Dicentrarchus labrax and Diplodus puntazzo. J Fish Biol. 2011 Mar;78(3):762-82.
molnova catalog
related products
-
HPK1-IN-4
HPK1-IN-4 is an HPK1 (MAPK41) inhibitor with an IC 50 of 0.061 nM. HPK1-IN-4 is often used as a preclinical immunotherapy tool compound.
-
SC-806
A potent, orally active p38 MAPK inhibitor with IC50 of 50 nM.
-
BMS-751324
BMS-751324 is a novel clinical prodrug of BMS-582949, which is a highly selective p38α MAPK inhibitor with IC50 of 13 nM.
